Atlas Trials

A Study of Cytisinicline for Vaping Cessation in Adult Smokers

Clinical trial NCT05431387 · COMPLETED

Trial details

NCT number
NCT05431387
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
VapingE-Cig Use
Start date
2022-07-13
Primary completion
2023-02-28
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.